NPPA issued the retail price of Tropicamide IP 0.2 mg + Phenylephrine Hydrochloride IP 3.1 mg + Lidocaine Hydrochloride IP 10 mg Injection for M/s Samarth Life Sciences Pvt. Ltd. (Manufacturer & Marketer)

Dec 04, 2025 | by TeamLease RegTech Legal Research Team

Free Legal updates for the week 00


Industry Specific ComplianceThe National Pharmaceutical Pricing Authority (NPPA) on December 03, 2025, issued a notification regarding the computation of the Retail Price of  Tropicamide IP 0.2 mg + Phenylephrine Hydrochloride IP 3.1 mg + Lidocaine Hydrochloride IP 10 mg Injection for M/s Samarth Life Sciences Pvt. Ltd. (Manufacturer & Marketer).

The following has been stated: -

• Each ml contains: Tropicamide IP 0.2 mg + Phenylephrine Hydrochloride IP 3.1 mg + Lidocaine Hydrochloride IP 10 mg Injection for M/s Samarth Life Sciences Pvt. Ltd. (Manufacturer & Marketer) will be 124.28.

[Notification No.:19(4901)/2025/DP/NPPA/Div.II]


Bookmark

Related Updates



Alternate Text

Get updates on the go on RegUpdate Mobile App.

NEW  ·  AI ASSISTANT